ReviewIntensive care medicine experimental2026
Blood-based biomarkers and delirium in critically ill adults in the ICU: a systematic review.
Review in Intensive care medicine experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDelirium is frequent and associated with increased health expenditures, unfavourable outcomes and increased mortality. Diagnosis currently relies on clinical scales and is often missed. However, blood-based biomarkers may represent a feasible tool to enhance risk stratification, early diagnosis, and monitoring. We aimed to identify blood-based biomarkers associated with delirium in adult intensive care unit patients, to provide a structured summary of the evidence, and to highlight gaps of knowledge to inform future research.
methodsA systematic literature search was performed in PubMed, EMBASE, The Cochrane Library, and Web of Science from inception to 3rd September 2025 with no date or language restrictions. Eligible studies were observational, assessing associations between blood-based biomarkers and delirium in critically ill adults admitted to an intensive care unit. The Newcastle-Ottawa Scale was applied to assess study quality. Data were qualitatively synthesized in a systematic narrative synthesis.
resultsOut of 2130 records including duplicates, 61 studies were included, comprising 39,355 adult patients, of whom 16,762 were screened positive for delirium. Delirium definition, assessment tools and frequency, reported delirium outcomes, and timing of biomarker sampling varied. In total, 153 blood-based biomarkers were identified, 101 were significantly associated with delirium and 40 were associated with delirium across two studies or more. Study quality was generally poor and substantial study heterogeneity limited comparability.
conclusionCurrent evidence does not support clinical use of any biomarker. Poor study quality, small sample sizes, and considerable methodological heterogeneity limit interpretation, generalizability, validation, and firm conclusions. Standardized methodology and international consensus are essential in future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.